A Controlled Study to Evaluate the Safety and Efficacy of Allogeneic MesenCure for the Treatment of Pulmonary Manifestations in Patients With COVID19
An open label clinical study to evaluate the safety and the efficacy of MesenCure, an allogeneic cell therapy product, for the treatment of the pulmonary manifestations in COVID19 patients
A Multicenter Study to Evaluate the Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II
The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as an autologous bone-regenerating graft in the reconstruction of deficient bone in two clinical indications:
Long and short bone extra-articular comminuted fracture
Long and short bones extra and intra articular defect /Gap or non-union, incapable of self-regeneration
Phase I/II Open Label First in Human Single Center Clinical Study Aimed to Evaluate the Safety and Efficacy of BonoFill-II in Reconstructing Maxillofacial Bone
The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as a bone filler containing the patient's own (autologous) adipose (fat) tissue-derived cells in reconstructing bone in two clinical indications:
Bone augmentation (e.g. sinus augmentation)
Bone grafting after removal of cysts from jaws
100 项与 BonusBio Group Ltd 相关的临床结果
0 项与 BonusBio Group Ltd 相关的专利（医药）
100 项与 BonusBio Group Ltd 相关的药物交易
100 项与 BonusBio Group Ltd 相关的转化医学
